Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C Virus (HCV)

Explore clinical trials studying Hepatitis C Virus (HCV). Study availability and eligibility vary by location and protocol.

27 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C Virus (HCV) trial results

Completed

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

NCT03212521

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Parkway Medical Center /ID# 161261 Birmingham, Alabama, United States
  • Arkansas Gastroenterology /ID# 161266 North Little Rock, Arkansas, United States
  • UC Davis Medical Center /ID# 161138 Sacramento, California, United States
  • Yale University /ID# 161258 New Haven, Connecticut, United States
View all 42 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

NCT03069365

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +23 more
Locations
  • Scripps Clinic /ID# 159116 La Jolla, California, United States
  • Huntington Medical Foundation /ID# 160653 Pasadena, California, United States
  • Tampa General Medical Group /ID# 159115 Tampa, Florida, United States
  • Northwest Louisiana Nephrology /ID# 160652 Shreveport, Louisiana, United States
View all 38 locations
View Trial Details
Completed

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

NCT01616524

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Precision Research Institute, Llc San Diego, California, United States
  • Medical Associates Research Group San Diego, California, United States
  • University Of California, San Francisco/Sf General Hospital San Francisco, California, United States
View all 124 locations
View Trial Details
Completed

Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C

NCT01754974

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Local Institution Hradec Králové, Czechia
  • Local Institution Prague, Czechia
  • Local Institution Ústí nad Labem, Czechia
  • Local Institution Guadalajara, Jalisco, Mexico
View all 16 locations
View Trial Details

Related conditions